347 250 (Cefprozil 250 mg)

Pill imprint 347 250 has been identified as Cefprozil 250 mg.

Cefprozil is used in the treatment of bladder infection; bronchitis; sinusitis; tonsillitis/pharyngitis; pneumonia (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefprozil 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 347 250 (Cefprozil 250 mg)

Cefprozil 250 mg 347 250
Cefprozil
Imprint:
347
250
Strength:
250 mg
Color:
White
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Second generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-5043
Inactive Ingredients:
hypromelloses
magnesium stearate
methylcellulose (400 mPa.s)
microcrystalline cellulose
polyethylene glycol 400
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Watch this video series to learn about managing severe allergies (anaphylaxis).

Close
Hide
(web2)